Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

ClinicalTrials.gov ID: NCT04286607

Public ClinicalTrials.gov record NCT04286607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.3% in Subjects With Chronic Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of ARQ-151 cream applied once a day for 24 weeks by subjects with chronic plaque psoriasis

Study identification

NCT ID
NCT04286607
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arcutis Biotherapeutics, Inc.
Industry
Enrollment
337 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2020 (Actual)
Primary completion
Jan 22, 2024 (Actual)
Completion
Jan 22, 2024 (Actual)
Last update posted
Sep 9, 2026

2020 – 2024

United States locations

U.S. sites
68
U.S. states
25
U.S. cities
61
Facility City State ZIP Site status
Arcutis Biotherapeutics Clinical Site 203 Scottsdale Arizona 85255 —
Arcutis Biotherapeutics Clinical Site 239 Beverly Hills California 90212 —
Arcutis Biotherapeutics Clinical Site 127 Encinitas California 92024 —
Arcutis Biotherapeutics Clinical Site 225 Encino California 91436 —
Arcutis Biotherapeutics Clinical Site 509 Fountain Valley California 92708 —
Arcutis Biotherapeutics Clinical Site 112 Fremont California 94538 —
Arcutis Biotherapeutics Clinical Site 120 Irvine California 92697 —
Arcutis Biotherapeutics Clinical Site 508 Los Angeles California 90057 —
Arcutis Biotherapeutics Clinical Site 511 Rancho Santa Margarita California 92688 —
Arcutis Biotherapeutics Clinical Site 123 San Diego California 92123 —
Arcutis Biotherapeutics Clinical Site 220 San Diego California 92123 —
Arcutis Biotherapeutics Clinical Site 136 San Francisco California 94132 —
Arcutis Biotherapeutics Clinical Site 208 Santa Monica California 90404 —
Arcutis Biotherapeutics Clinical Site 215 Santa Monica California 90503 —
Arcutis Biotherapeutics Clinical Site 223 Boynton Beach Florida 91436 —
Arcutis Biotherapeutics Clinical Site 237 DeLand Florida 32720 —
Arcutis Biotherapeutics Clinical Site 118 Delray Beach Florida 33484 —
Arcutis Biotherapeutics Clinical Site 202 Hialeah Florida 33016 —
Arcutis Biotherapeutics Clinical Site 228 Largo Florida 33770 —
Arcutis Biotherapeutics Clinical Site 131 Miami Florida 33174 —
Arcutis Biotherapeutics Clinical Site 201 North Miami Beach Florida 33162 —
Arcutis Biotherapeutics Clinical Site 137 Ocala Florida 34470 —
Arcutis Biotherapeutics Clinical Site 105 Sanford Florida 32771 —
Arcutis Biotherapeutics Clinical Site 209 Sweetwater Florida 33172 —
Arcutis Clinical Site 602 Boise Idaho 83706 —
Arcutis Biotherapeutics Clinical Site 114 Plainfield Illinois 46168 —
Arcutis Biotherapeutics Clinical Site 102 Rolling Meadows Illinois 60008 —
Arcutis Biotherapeutics Clinical Site 214 Indianapolis Indiana 46250 —
Arcutis Biotherapeutics Clinical Site 217 Louisville Kentucky 40217 —
Arcutis Biotherapeutics Clinical Site 111 Baton Rouge Louisiana 70809 —
Arcutis Biotherapeutics Clinical Site 211 Lake Charles Louisiana 70605 —
Arcutis Biotherapeutics Clinical Site 213 Metairie Louisiana 70006 —
Arcutis Biotherapeutics Clinical Site 224 New Orleans Louisiana 70115 —
Arcutis Biotherapeutics Clinical Site 125 Rockville Maryland 20850 —
Arcutis Biotherapeutics Clinical Site 138 Rockville Maryland 20850 —
Arcutis Biotherapeutics Clinical Site 101 Brighton Massachusetts 02135 —
Arcutis Biotherapeutics Clinical Site 116 Clinton Township Michigan 48038 —
Arcutis Biotherapeutics Clinical Site 212 Detroit Michigan 48202 —
Arcutis Biotherapeutics Clinical Site 216 Fridley Minnesota 55432 —
Arcutis Biotherapeutics Clinical Site 227 Saint Joseph Missouri 64506 —
Arcutis Biotherapeutics Clinical Site 219 Las Vegas Nevada 89148 —
Arcutis Biotherapeutics Clinical Site 231 Las Vegas Nevada 89148 —
Arcutis Biotherapeutics Clinical Site 139 Reno Nevada 89509 —
Arcutis Biotherapeutics Clinical Site 240 Reno Nevada 89703 —
Arcutis Biotherapeutics Clinical Site 236 Portsmouth New Hampshire 03801 —
Arcutis Biotherapeutics Clinical Site 129 East Windsor New Jersey 08520 —
Arcutis Biotherapeutics Clinical Site 121 New York New York 10029 —
Arcutis Biotherapeutics Clinical Site 130 Rochester New York 14623 —
Arcutis Biotherapeutics Clinical Site 108 Stony Brook New York 11790 —
Arcutis Biotherapeutics Clinical Site 115 High Point North Carolina 27262 —
Arcutis Biotherapeutics Clinical Site 124 Fairborn Ohio 45324 —
Arcutis Biotherapeutics Clinical Site 222 Oklahoma City Oklahoma 73112 —
Arcutis Biotherapeutics Clinical Site 134 Oklahoma City Oklahoma 73118 —
Arcutis Biotherapeutics Clinical Site 229 Broomall Pennsylvania 19008 —
Arcutis Biotherapeutics Clinical Site 128 Duncansville Pennsylvania 16635 —
Arcutis Biotherapeutics Clinical Site 113 Exton Pennsylvania 19003 —
Arcutis Biotherapeutics Clinical Site 135 Pittsburgh Pennsylvania 15213 —
Arcutis Biotherapeutics Clinical Site 233 Knoxville Tennessee 37922 —
Arcutis Biotherapeutics Clinical Site 221 Murfreesboro Tennessee 37130 —
Arcutis Biotherapeutics Clinical Site 206 Arlington Texas 76011 —
Arcutis Biotherapeutics Clinical Site 104 College Station Texas 77845 —
Arcutis Biotherapeutics Clinical Site 119 Dallas Texas 75246 —
Arcutis Biotherapeutics Clinical Site 519 Frisco Texas 75034 —
Arcutis Biotherapeutics Clinical Site 238 Houston Texas 77030 —
Arcutis Biotherapeutics Clinical Site 110 San Antonio Texas 78218 —
Arcutis Biotherapeutics Clinical Site 117 San Antonio Texas 78229 —
Arcutis Biotherapeutics Clinical Site 210 West Jordan Utah 84088 —
Arcutis Biotherapeutics Clinical Site 230 Richmond Virginia 23220 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04286607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04286607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →